425 related articles for article (PubMed ID: 23065472)
1. Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing.
Chan KC; Jiang P; Zheng YW; Liao GJ; Sun H; Wong J; Siu SS; Chan WC; Chan SL; Chan AT; Lai PB; Chiu RW; Lo YM
Clin Chem; 2013 Jan; 59(1):211-24. PubMed ID: 23065472
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing.
Chan KC; Jiang P; Chan CW; Sun K; Wong J; Hui EP; Chan SL; Chan WC; Hui DS; Ng SS; Chan HL; Wong CS; Ma BB; Chan AT; Lai PB; Sun H; Chiu RW; Lo YM
Proc Natl Acad Sci U S A; 2013 Nov; 110(47):18761-8. PubMed ID: 24191000
[TBL] [Abstract][Full Text] [Related]
3. Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments.
Sun K; Jiang P; Chan KC; Wong J; Cheng YK; Liang RH; Chan WK; Ma ES; Chan SL; Cheng SH; Chan RW; Tong YK; Ng SS; Wong RS; Hui DS; Leung TN; Leung TY; Lai PB; Chiu RW; Lo YM
Proc Natl Acad Sci U S A; 2015 Oct; 112(40):E5503-12. PubMed ID: 26392541
[TBL] [Abstract][Full Text] [Related]
4. Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients.
Jiang P; Chan CW; Chan KC; Cheng SH; Wong J; Wong VW; Wong GL; Chan SL; Mok TS; Chan HL; Lai PB; Chiu RW; Lo YM
Proc Natl Acad Sci U S A; 2015 Mar; 112(11):E1317-25. PubMed ID: 25646427
[TBL] [Abstract][Full Text] [Related]
5. Abnormal plasma DNA profiles in early ovarian cancer using a non-invasive prenatal testing platform: implications for cancer screening.
Cohen PA; Flowers N; Tong S; Hannan N; Pertile MD; Hui L
BMC Med; 2016 Aug; 14(1):126. PubMed ID: 27558279
[TBL] [Abstract][Full Text] [Related]
6. Massively-parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary.
Tothill RW; Li J; Mileshkin L; Doig K; Siganakis T; Cowin P; Fellowes A; Semple T; Fox S; Byron K; Kowalczyk A; Thomas D; Schofield P; Bowtell DD
J Pathol; 2013 Dec; 231(4):413-23. PubMed ID: 24037760
[TBL] [Abstract][Full Text] [Related]
7. Massively parallel sequencing of cell-free DNA in plasma for detecting gynaecological tumour-associated copy number alteration.
Nakabayashi M; Kawashima A; Yasuhara R; Hayakawa Y; Miyamoto S; Iizuka C; Sekizawa A
Sci Rep; 2018 Jul; 8(1):11205. PubMed ID: 30046040
[TBL] [Abstract][Full Text] [Related]
8. Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing.
Leary RJ; Sausen M; Kinde I; Papadopoulos N; Carpten JD; Craig D; O'Shaughnessy J; Kinzler KW; Parmigiani G; Vogelstein B; Diaz LA; Velculescu VE
Sci Transl Med; 2012 Nov; 4(162):162ra154. PubMed ID: 23197571
[TBL] [Abstract][Full Text] [Related]
9. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
[TBL] [Abstract][Full Text] [Related]
10. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
Pécuchet N; Legras A; Laurent-Puig P; Blons H
Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
[TBL] [Abstract][Full Text] [Related]
11. Preferred end coordinates and somatic variants as signatures of circulating tumor DNA associated with hepatocellular carcinoma.
Jiang P; Sun K; Tong YK; Cheng SH; Cheng THT; Heung MMS; Wong J; Wong VWS; Chan HLY; Chan KCA; Lo YMD; Chiu RWK
Proc Natl Acad Sci U S A; 2018 Nov; 115(46):E10925-E10933. PubMed ID: 30373822
[TBL] [Abstract][Full Text] [Related]
12. Detection of Circulating Tumor DNA in the Blood of Cancer Patients: An Important Tool in Cancer Chemoprevention.
Ulz P; Auer M; Heitzer E
Methods Mol Biol; 2016; 1379():45-68. PubMed ID: 26608289
[TBL] [Abstract][Full Text] [Related]
13. Plasma nucleic acid analysis by massively parallel sequencing: pathological insights and diagnostic implications.
Lo YM; Chiu RW
J Pathol; 2011 Nov; 225(3):318-23. PubMed ID: 21984122
[TBL] [Abstract][Full Text] [Related]
14. Genomic variations in plasma cell free DNA differentiate early stage lung cancers from normal controls.
Xia S; Huang CC; Le M; Dittmar R; Du M; Yuan T; Guo Y; Wang Y; Wang X; Tsai S; Suster S; Mackinnon AC; Wang L
Lung Cancer; 2015 Oct; 90(1):78-84. PubMed ID: 26233568
[TBL] [Abstract][Full Text] [Related]
15. SAAS-CNV: A Joint Segmentation Approach on Aggregated and Allele Specific Signals for the Identification of Somatic Copy Number Alterations with Next-Generation Sequencing Data.
Zhang Z; Hao K
PLoS Comput Biol; 2015 Nov; 11(11):e1004618. PubMed ID: 26583378
[TBL] [Abstract][Full Text] [Related]
16. Performance of a TthPrimPol-based whole genome amplification kit for copy number alteration detection using massively parallel sequencing.
Deleye L; De Coninck D; Dheedene A; De Sutter P; Menten B; Deforce D; Van Nieuwerburgh F
Sci Rep; 2016 Aug; 6():31825. PubMed ID: 27546482
[TBL] [Abstract][Full Text] [Related]
17. A novel framework for analyzing somatic copy number aberrations and tumor subclones for paired heterogeneous tumor samples.
Xia H; Li A; Yu Z; Liu X; Feng H
Biomed Mater Eng; 2015; 26 Suppl 1():S1845-53. PubMed ID: 26405956
[TBL] [Abstract][Full Text] [Related]
18. Ready to clone: CNV detection and breakpoint fine-mapping in breast and ovarian cancer susceptibility genes by high-resolution array CGH.
Hackmann K; Kuhlee F; Betcheva-Krajcir E; Kahlert AK; Mackenroth L; Klink B; Di Donato N; Tzschach A; Kast K; Wimberger P; Schrock E; Rump A
Breast Cancer Res Treat; 2016 Oct; 159(3):585-90. PubMed ID: 27581129
[TBL] [Abstract][Full Text] [Related]
19. Implication of genomic characterization in synchronous endometrial and ovarian cancers of endometrioid histology.
Chao A; Wu RC; Jung SM; Lee YS; Chen SJ; Lu YL; Tsai CL; Lin CY; Tang YH; Chen MY; Huang HJ; Chou HH; Huang KG; Chang TC; Wang TH; Lai CH
Gynecol Oncol; 2016 Oct; 143(1):60-67. PubMed ID: 27498588
[TBL] [Abstract][Full Text] [Related]
20. Trunk mutational events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinoma.
Torrecilla S; Sia D; Harrington AN; Zhang Z; Cabellos L; Cornella H; Moeini A; Camprecios G; Leow WQ; Fiel MI; Hao K; Bassaganyas L; Mahajan M; Thung SN; Villanueva A; Florman S; Schwartz ME; Llovet JM
J Hepatol; 2017 Dec; 67(6):1222-1231. PubMed ID: 28843658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
